Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

febuprol

Known as: 3-butoxy-1-phenoxy-propanol-(2) 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
OBJECTIVE:To develop a HPLC method for the determination of the principal agent in febuprol pills.METHODS:The principal agent was… Expand
Is this relevant?
1991
1991
  • Li Rui
  • 1991
  • Corpus ID: 204578060
 
Is this relevant?
1988
1988
The effect of a new potent choleretic drug (Febuprol) on lipid composition and cholesterol nucleation time in gallbladder bile… Expand
Is this relevant?
1987
1987
10 patients with right upper quadrant pain were treated with a choleretic agent (Febuprol; 3 X 200 mg t. i. d.) and placebo in a… Expand
Is this relevant?
1983
1983
In a clinical trial, performed according to new criteria of the AMG (Arzneimittelgesetz) 1976, a new choleretic monosubstance 3-n… Expand
Is this relevant?
1978
1978
In previous pharmacological experiments with the choleretic agent Febuprol, healthy subjects showed a significant increase in… Expand
Is this relevant?
1977
1977
The spasmolytic activity of 3-butoxy-1-phenoxy-propanol-(2) (febuprol) on the biliary tract is demonstrated in two different… Expand
Is this relevant?
1976
1976
The pharmacokinetic behaviour as well as metabolization of 3-butoxy - 1 - phenoxy-propanol-(2) (febuprol) in rats and mice were… Expand
Is this relevant?
1976
1976
The choleretic effect of 3-butoxy-1-phenoxypropanol-(2), Febuprol (INN), was examined in healthy volunteer subjects. In a dose… Expand
Is this relevant?